Insights

Primary percutaneous coronary intervention (PCI) is effective in older acute myocardial infarction (AMI) patients, but carries a higher risk of bleeding and mortality. Caution is advised with antithrombotic drugs in the elderly.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute myocardial infarction (AMI), especially in elderly patients (>75 years) due to the high hemorrhagic risk associated with thrombolysis.
  • The study addresses the need to understand age-related outcomes in AMI patients undergoing primary PCI.

Purpose of the Study:

  • To evaluate the impact of age on clinical outcomes and in-hospital mortality in patients with AMI undergoing primary PCI.
  • To compare outcomes between patients over 75 years old and younger patients receiving primary PCI.

Main Methods:

  • A cohort of 245 consecutive patients (31-90 years) undergoing primary PCI between January 2000 and December 2001 was analyzed.
  • Forty-six patients (18.8%) aged over 75 were compared with the remaining younger patients.
  • Key parameters included cardiovascular risk factors, prior cardiac events, extent of coronary disease, angiographic results, and in-hospital mortality.

Main Results:

  • Older patients were more frequently female (56.5% vs. 23.1%) and had higher rates of multivessel coronary disease (41.3% vs. 26.2%).
  • PCI success rates were high and similar in both groups (93.5% vs. 96.7%).
  • Elderly patients experienced higher rates of hemorrhagic complications (13.0% vs. 3.5%) and in-hospital mortality (19.6% vs. 4.5%).

Conclusions:

  • Primary PCI demonstrates high success rates in elderly patients with AMI.
  • Despite high success, elderly patients face increased in-hospital mortality and hemorrhagic complications.
  • Increased caution with adjuvant antithrombotic therapy is recommended for older individuals undergoing primary PCI.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...